ARK Investment Management LLC 13D and 13G filings for Fate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 2:37 pm Sale | 2021-12-31 | 13G | Fate Therapeutics, Inc. FATE | ARK Investment Management LLC | 10,312,167 10.800% | -478,256 (-4.43%) | Filing |
| 2021-09-10 2:48 pm Purchase | 2021-08-31 | 13G | Fate Therapeutics, Inc. FATE | ARK Investment Management LLC | 10,790,423 11.340% | 10,790,423 (New Position) | Filing |